0001574774-18-000015.txt : 20180314 0001574774-18-000015.hdr.sgml : 20180314 20180314182558 ACCESSION NUMBER: 0001574774-18-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180313 FILED AS OF DATE: 20180314 DATE AS OF CHANGE: 20180314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Broadway Fred CENTRAL INDEX KEY: 0001557180 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55039 FILM NUMBER: 18690605 MAIL ADDRESS: STREET 1: 227 WASHINGTON STREET STREET 2: SUITE 210 CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOTELEMETRY, INC. CENTRAL INDEX KEY: 0001574774 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 462568498 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 CEDAR HOLLOW ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-729-7000 MAIL ADDRESS: STREET 1: 1000 CEDAR HOLLOW ROAD CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: BioTelemetry, Inc. DATE OF NAME CHANGE: 20130418 4 1 wf-form4_152106634468346.xml FORM 4 X0306 4 2018-03-13 0 0001574774 BIOTELEMETRY, INC. BEAT 0001557180 Broadway Fred 1000 CEDAR HOLLOW RD. SUITE 102 MALVERN PA 19355 0 1 0 0 President BioTel Heart Common Stock 2018-03-13 4 M 0 40000 16.59 A 64880 D Common Stock 2018-03-13 4 M 0 10000 6.95 A 74880 D Common Stock 2018-03-13 4 M 0 4158 8.79 A 79038 D Common Stock 2018-03-13 4 S 0 54158 34.17 D 24880 D Stock Options (Right to Buy) 16.59 2018-03-13 4 M 0 40000 0 D 2019-06-29 Common Stock 40000.0 0 D Stock Options (Right to Buy) 6.95 2018-03-13 4 M 0 10000 0 D 2019-08-12 Common Stock 10000.0 0 D Stock Options (Right to Buy) 8.79 2018-03-13 4 M 0 4158 0 D 2020-05-10 Common Stock 4158.0 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2018. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $33.70 to $35.60, inclusive. The reporting person undertakes to provide to BioTelemetry, Inc., any security holder of BioTelemetry, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The stock options vested in four equal annual installments which began on December 31, 2009. The options were fully exercisable as of December 31, 2012. The stock options vested in four equal annual installments which began on December 31, 2010. The options were fully exercisable as of December 31, 2013. /s/ Peter F. Ferola, Attorney-in-Fact 2018-03-14